Basal-shift transformation leads to EGFR therapy-resistance in human lung adenocarcinoma
Author
Abstract
Suggested Citation
DOI: 10.1038/s41467-025-59623-3
Download full text from publisher
References listed on IDEAS
- Minsuh Kim & Hyemin Mun & Chang Oak Sung & Eun Jeong Cho & Hye-Joon Jeon & Sung-Min Chun & Da Jung Jung & Tae Hoon Shin & Gi Seok Jeong & Dong Kwan Kim & Eun Kyung Choi & Seong-Yun Jeong & Alison M. T, 2019. "Patient-derived lung cancer organoids as in vitro cancer models for therapeutic screening," Nature Communications, Nature, vol. 10(1), pages 1-15, December.
- Juliann Chmielecki & Tony Mok & Yi-Long Wu & Ji-Youn Han & Myung-Ju Ahn & Suresh S. Ramalingam & Thomas John & Isamu Okamoto & James Chih-Hsin Yang & Frances A. Shepherd & Krishna C. Bulusu & Gianluca, 2023. "Analysis of acquired resistance mechanisms to osimertinib in patients with EGFR-mutated advanced non-small cell lung cancer from the AURA3 trial," Nature Communications, Nature, vol. 14(1), pages 1-8, December.
- Hirokazu Taniguchi & Tadaaki Yamada & Rong Wang & Keiko Tanimura & Yuta Adachi & Akihiro Nishiyama & Azusa Tanimoto & Shinji Takeuchi & Luiz H. Araujo & Mariana Boroni & Akihiro Yoshimura & Shinsuke S, 2019. "AXL confers intrinsic resistance to osimertinib and advances the emergence of tolerant cells," Nature Communications, Nature, vol. 10(1), pages 1-14, December.
- Jana Fassunke & Fabienne Müller & Marina Keul & Sebastian Michels & Marcel A. Dammert & Anna Schmitt & Dennis Plenker & Jonas Lategahn & Carina Heydt & Johannes Brägelmann & Hannah L. Tumbrink & Yanni, 2018. "Overcoming EGFRG724S-mediated osimertinib resistance through unique binding characteristics of second-generation EGFR inhibitors," Nature Communications, Nature, vol. 9(1), pages 1-13, December.
- Rong Wang & Tadaaki Yamada & Kenji Kita & Hirokazu Taniguchi & Sachiko Arai & Koji Fukuda & Minoru Terashima & Akihiko Ishimura & Akihiro Nishiyama & Azusa Tanimoto & Shinji Takeuchi & Koshiro Ohtsubo, 2020. "Transient IGF-1R inhibition combined with osimertinib eradicates AXL-low expressing EGFR mutated lung cancer," Nature Communications, Nature, vol. 11(1), pages 1-14, December.
Most related items
These are the items that most often cite the same works as this one and are cited by the same works as this one.- Fan Chen & Aria L. Byrd & Jinpeng Liu & Robert M. Flight & Tanner J. DuCote & Kassandra J. Naughton & Xiulong Song & Abigail R. Edgin & Alexsandr Lukyanchuk & Danielle T. Dixon & Christian M. Gosser &, 2023. "Polycomb deficiency drives a FOXP2-high aggressive state targetable by epigenetic inhibitors," Nature Communications, Nature, vol. 14(1), pages 1-18, December.
- Sarah Figarol & Célia Delahaye & Rémi Gence & Aurélia Doussine & Juan Pablo Cerapio & Mathylda Brachais & Claudine Tardy & Nicolas Béry & Raghda Asslan & Jacques Colinge & Jean-Philippe Villemin & Ant, 2024. "Farnesyltransferase inhibition overcomes oncogene-addicted non-small cell lung cancer adaptive resistance to targeted therapies," Nature Communications, Nature, vol. 15(1), pages 1-15, December.
- Julia Ogden & Robert Sellers & Sudhakar Sahoo & Anthony Oojageer & Anshuman Chaturvedi & Caroline Dive & Carlos Lopez-Garcia, 2025. "A human model to deconvolve genotype-phenotype causations in lung squamous cell carcinoma," Nature Communications, Nature, vol. 16(1), pages 1-17, December.
- Louisa L. Y. Chan & Danielle E. Anderson & Hong Sheng Cheng & Fransiskus Xaverius Ivan & Si Chen & Adrian E. Z. Kang & Randy Foo & Akshamal M. Gamage & Pei Yee Tiew & Mariko Siyue Koh & Ken Cheah Hooi, 2022. "The establishment of COPD organoids to study host-pathogen interaction reveals enhanced viral fitness of SARS-CoV-2 in bronchi," Nature Communications, Nature, vol. 13(1), pages 1-18, December.
- Kyu Jin Song & Seunghyuk Choi & Kwoneel Kim & Hee Sang Hwang & Eunhyong Chang & Ji Soo Park & Seok Bo Shim & Seunghwan Choi & Yong Jin Heo & Woo Ju An & Dae Yeol Yang & Kyung-Cho Cho & Wonjun Ji & Cha, 2024. "Proteogenomic analysis reveals non-small cell lung cancer subtypes predicting chromosome instability, and tumor microenvironment," Nature Communications, Nature, vol. 15(1), pages 1-25, December.
- Ranjan Preet & Md Atiqul Islam & Jiyoung Shim & Ganeshkumar Rajendran & Amrita Mitra & Vikalp Vishwakarma & Caleb Kutz & Sonali Choudhury & Harsh Pathak & Qun Dai & Weijing Sun & Rashna Madan & Cuncon, 2025. "Gut commensal Bifidobacterium-derived extracellular vesicles modulate the therapeutic effects of anti-PD-1 in lung cancer," Nature Communications, Nature, vol. 16(1), pages 1-19, December.
- Rebecca S. Schneider & Elisa B. Nieves & Bhavay Aggarwal & Annie C. Bowles-Welch & Hazel Y. Stevens & Linda E. Kippner & Scott D. Boden & Kenneth Mautner & Hicham Drissi & Krishnendu Roy & Wilbur A. L, 2025. "On-chip 3D potency assay for prediction of clinical outcomes for cell therapy candidates for osteoarthritis," Nature Communications, Nature, vol. 16(1), pages 1-12, December.
Corrections
All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:nat:natcom:v:16:y:2025:i:1:d:10.1038_s41467-025-59623-3. See general information about how to correct material in RePEc.
If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.
If CitEc recognized a bibliographic reference but did not link an item in RePEc to it, you can help with this form .
If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.
For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Sonal Shukla or Springer Nature Abstracting and Indexing (email available below). General contact details of provider: http://www.nature.com .
Please note that corrections may take a couple of weeks to filter through the various RePEc services.